TECX – tectonic therapeutic, inc. (US:NASDAQ)
Stock Stats
News
Tectonic Therapeutic (NASDAQ: TECX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $65.00 price target on the stock.
Tectonic Therapeutic Inc. Reports Q3 2024 Results [Yahoo! Finance]
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $79.00. They now have an "overweight" rating on the stock.
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Leerink Partners from $49.00 to $69.00. They now have an "outperform" rating on the stock.
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
Form SC 13G/A Tectonic Therapeutic, Filed by: Newtyn Management, LLC
Form 10-Q Tectonic Therapeutic, For: Sep 30
Form 8-K Tectonic Therapeutic, For: Nov 07
Form SC 13D/A Tectonic Therapeutic, Filed by: Atlas Venture Fund X, L.P.
Form SC 13D/A Tectonic Therapeutic, Filed by: SPRINGER TIMOTHY A
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.